Despite recent boosts in FDA drug approvals, industry faces hurdles in sustaining returns on R&D investments. How can companies demonstrate that their products are not only safe and effective but differentiated from current standards of care? Competitive, cultural and collaborative considerations are barriers to harnessing and translating data meaningfully. Officials from highly successful research organizations will discuss challenges and best practices in capturing and analyzing “big data” in R&D. Topics will include how to combine real-world outcomes data with clinical data, design more efficient clinical trials and mine genetic data.

Key Takeaways:

  • Apply advanced analytics to improve the efficiency of clinical trials
  • Identify sources of clinical and real-world big data
  • Unlock the secrets of accessing these clinical and real-world big data

Ability Level: Advanced

Session ID: 2434

myBIO Chatter
Educational Topics